• SENSEX 80,998.25
    260.74 (+0.32%)
  • BANKNIFTY 55,676.85
    76.90 (+0.14%)
  • Alkem Lab
    4,855.10 4,409.90(%)
  • Tata Technolog.
    748.30 595.05(%)
  • Aditya Bir. Fas.
    76.10 76.10(%)
  • Kaynes Tech
    5,550.00 2,811.20(%)
  • Indegene
    585.90 468.90(%)
  • Cochin Shipyard
    2,175.00 2,977.10(%)
  • Reliance Power
    62.12 62.80(%)
  • Ircon Intl.
    223.60 351.65(%)
  • Garden Reach Sh.
    3,464.85 3,464.85(%)
  • Suzlon Energy
    66.55 45.13(%)
  • Swiggy
    365.00 617.00(%)
  • Mazagon Dock
    3,406.00 1,200.00(%)
  • Rail Vikas
    434.70 647.00(%)
  • Choice Intl.
    707.75 718.00(%)
  • Eternal Ltd
    247.90 304.50(%)
  • Railtel Corpn.
    449.20 618.00(%)
  • Swan Energy
    463.80 809.70(%)
  • Sika Interplant
    1,125.30 1,125.30(%)
  • Reliance Infra.
    385.90 385.90(%)
  • Vodafone Idea
    6.94 19.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Beta Drugs Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 71606.0
  • ISIN : INE351Y01019
1,894.00 40 (2.17%)
  • As on 04 Jun 2025 (EOD)

  • Today’s Low

    1,850.00

  • Today’s High

    1,899.95

  • Open

    1,850.00

  • Perv Close

    1,853.75

  • 52W Low

    1,047.62

  • 52W High

    2,215.24

Key Indicators

  • P/E(TTM)

    101.94

  • Mar.Cap (₹Cr.)

    1,911.91

  • Div & Yield %

    0.00

  • Book Value(₹)

    127.83

  • Debt-Equity Ratio

    2.17

  • AGM Date

    04-Jun-2025

  • EPS

    18.58

  • P/E Ratio

    101.94

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    1,911.91

  • RONW (%)

    26.03

  • ROCE (%)

    31.58

Score Board

  • Equity (₹ in Cr.)

    10.09

  • BV (₹)

    127.80

  • Sales( ₹ in Cr.)

    220.20

  • NP (in Cr.)

    18.75

  • NP Var(%)

    -15.0

  • Div%

    0.0

  • CPS (₹)

    25.90

  • EPS (₹)

    18.60

  • Traded Value (₹ in Lakhs)

    1,911.91

  • 52 Week High

    2,215.24

  • 52 Week Low

    1,047.62

  • Price BSE

    0.0

  • Price NSE

    1,894.00

  • Market Capital( in Cr.)

    1,911.91

  • P/C Ratio

    73.00

  • P/E Ratio

    102.00

  • Price Vs.BV

    18.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 197.62 157.87 124.85 79.46 65.32 58.05
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 197.62 157.87 124.85 79.46 65.32 58.05
Other Income 1.73 1.04 0.86 0.61 0.42 0.32
Stock Adjustments 6.98 3.17 -0.86 1.38 -0.20 2.67
Total Income 206.33 162.08 124.85 81.45 65.54 61.04
EXPENDITURE :            
Raw Materials 119.27 86.47 69.86 44.83 34.61 33.28
Power and Fuel Cost 3.83 3.06 2.28 1.84 1.46 1.05
Employee Cost 11.08 10.31 6.70 4.53 3.70 2.45
Other Manufacturing Expenses 13.53 12.51 10.04 7.65 6.64 6.52
Selling and Administration Expenses 22.74 17.08 9.61 6.23 6.59 6.39
Miscellaneous Expenses 0.62 0.42 0.31 0.45 0.37 0.73
Employee Benefit Expenses 11.08 10.31 6.70 4.53 3.70 2.45
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 171.07 129.85 98.80 65.53 53.36 50.42
Operating Profit 35.26 32.24 26.04 15.92 12.17 10.62
Interest 1.05 0.84 0.41 0.77 0.64 0.73
Gross Profit 34.21 31.40 25.63 15.15 11.53 9.89
Depreciation 4.72 6.19 5.47 5.27 2.58 2.42
Profit Before Tax 29.49 25.21 20.16 9.88 8.95 7.47
Current Tax 7.47 6.68 6.15 3.30 1.72 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.08 -0.29 -0.24 -0.40 0.13 -0.25
Reported Net Profit 21.94 18.82 14.25 6.98 7.10 7.71
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 21.94 18.82 14.25 6.98 7.10 7.71
Adjustment below Net Profit -2.18 -0.02 -0.20 0.00 0.00 0.00
P & L Balance brought forward 62.70 43.91 29.86 22.89 15.79 8.07
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 82.46 62.70 43.91 29.86 22.89 15.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 22.82 19.57 14.82 7.26 7.39 8.92
Earnings Per Share(Adj)-Unit Curr 22.82 18.64 14.82 6.91 7.04 8.49
Book Value 120.67 100.12 80.57 65.96 58.71 46.93
Book Value(Adj)-Unit Curr 120.67 95.35 80.57 62.82 55.92 44.69

Shareholding Pattern

  • Promoter Group

    66.73%

  • Public Share Holding

    33.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,736,507 66.73 6,736,507 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 6,736,507 66.73 6,736,507 5
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 91,035 0.90 91,035 4
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 16,663 0.17 16,663 4
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 107,698 1.07 107,698 8
2] Non Institution
Bodies Corporate 864,301 8.56 864,301 51
Clearing Members 105 0.00 105 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 108,990 1.08 108,990 172
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 59,955 0.59 59,955 76
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 924,630 9.16 924,630 8
Individuals holding nominal share capital up to Rs. 1 lakh 1,277,139 12.65 1,277,129 2,726
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 20 0.00 20 1
Sub Total 3,250,348 32.20 3,250,338 3,041
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 10,094,553 100.00 10,094,543 3,054

Company Background

Beta Drugs LtdPharmaceuticals - Indian - Bulk Drugs

  • Beta Drugs Ltd
  • BSE Code : 71606.0
  • ISIN : INE351Y01019

  • Incorporation Year

    2005

  • Registered Office

    Village Nandpur
    , Baddi,
    Himachal Pradesh-174101

  • Telephone

    91-1795-236196

  • FAX

  • Chairman

    Rahul Batra

  • Managing Director

    Varun Batra

  • Company Secretary

    Rajni Brar

  • Auditor

    Kalra Rai & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Beta Drugs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Beta Drugs Ltd 1,894.00 199.35 197.62 123.87 26.60
Abbott India 31,282.70 6,097.18 5,848.91 47.00 44.71
Astrazeneca Phar 9,487.50 1,330.33 1,295.53 204.91 33.26
P & G Health Ltd 5,605.70 1,166.89 1,151.26 37.05 39.76
Glaxosmi. Pharma 3,427.35 3,530.73 3,407.25 63.18 44.44
Cipla 1,472.20 17,645.00 16,574.34 23.05 20.10
Amrutanjan Healt 740.45 437.58 421.23 42.12 20.84
Guj. Themis Bio. 332.55 174.19 169.82 74.23 44.82
Fermenta Biotec. 318.30 315.24 307.09 13.86 4.10
Bliss GVS Pharma 133.25 638.96 605.46 20.34 11.19
Ambalal Sarabhai 36.95 11.70 3.81 34.21 1.92